Weekly Digest – February 2026 Weekly Digest – February 2026 14 February 2026: Alphamab Oncology announces the first patient dosed in a phase 3 clinical study for colorectal cancer of biparatopic HER2-targeting ADC JSKN003 Alphamab Oncology announced that the first […]
Contact:
info@ciscientists.com
+1-908-212-7484
Optimal Dose
For a subscription, please provide your email id